ALT, Altimmune, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for ALT

History

Run pick agents

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, Bear Picks, and more.


Short Seller Reports & Red Flags:

News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask ALT by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(MRNA) Moderna, Inc
(NVAX) Novavax, Inc

Latest YouTube Video:

Unlock YouTube Video by Subscribing to iPick.ai Premium!



Billionaire Connection

Not available

Business Profile

Address: 910 Clopper Road, Suite 201S, Gaithersburg, MD, United States, 20878

Employees: 57

Business Summary

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Leadership and Board

Mr. Jerome Benedict Durso

Chairman, CEO & President

Dr. M. Scot Roberts Ph.D.

Chief Scientific Officer

Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.

Chief Medical Officer

Mr. Gregory L. Weaver CPA, M.B.A.

Chief Financial Officer

Mr. Richard Menziuso

VP, Global Controller & Principal Accounting Officer

Mr. Bertrand Georges Ph.D.

Chief Technology Officer

Mr. Luis Sanay C.F.A.

Vice President of Investor Relations

Mr. Tony Blandin B.S.

Vice President of Quality & Compliance Management

Ms. Robin E. Abrams J.D.

Chief Legal Officer & Corporate Secretary

Mr. Raymond M. Jordt M.B.A., M.S.

Chief Business Officer